ADHD, sleep and Depression: Treatment, Research and Education


Brainclinics, founded in 2001 and located in Nijmegen The Netherlands, has been doing dedicated research and treatment of concentration, sleep and mood problems such as occur with ADHD, depression and insomnia. Through years of treatment and research experience in this field, we are nationally and internationally seen as an important and specialized treatment (neuroCare Clinics) and research institute. 


Starting January 1st 2016 our new clinics in the Hague (NL) and Munich (Germany) will open their doors!

In order to provide you with appropriate information, you can choose from the following options (see tabs at the top of this page): 




Psychologenpraktijk Brainclinics: Behandeling en therapie van ADHD (neurofeedback), Depressie (rTMS) en slaapproblemen Psychology Practice

Psychology practice Brainclinics / neuroCare Clinics are innovative psychology practices specialized in Neurofeedback treatment for ADHD and insomnia and magnetic brain stimulation also called rTMS for the treatment of Depression and OCD. Furthermore, these treatments are embedded with psychotherapy and coaching. This section of the website provides additional information about the treatment methods rTMS and Neurofeedback as well as different ways to cope with sleep issues and insomnia, but also client experiences and frequently asked questions regarding these treatments. You will also find scientific backgrounds and practical information about Neurofeedback and rTMS. Brainclinics and neuroCare clinics are specialized in therapy and treatment of Depression, sleep-problems, insomnia and ADHD. Click here for more information on sleep, tablets and ADHD


Psychologenpraktijk Brainclinics: Behandeling en therapie van ADHD (neurofeedback), Depressie (rTMS) en slaapproblemen Research Institute

Are you looking for more scientific background on neuromodulation techniques such as rTMS and Neurofeedback or quantitative EEG (QEEG), or do you want to know more about our ongoing studies (iSPOT with ADHD or depression, or sleep studies), look at our research institute.


Psychologenpraktijk Brainclinics: Behandeling en therapie van ADHD (neurofeedback), Depressie (rTMS) en slaapproblemen Education for professionals

Are you, as a professional, looking for training in the field of neurofeedback, rTMS, QEEG or sleep and chronobiology, look at Brainclinics Education / neuroCademy. It has been established to share our extensive treatment and research experience in rTMS, Neurofeedback, sleep problems and QEEG.  Brainclinics Education and our neuroCademy is registered in the Central Register of Vocational Education, is a "BCIA accredited" Neurofeedback training institute and our rTMS, Neurofeedback, sleep and QEEG and Personalized Medicine courses and workshops are accredited by most acknowledged professional organizations such as the NIP, NVvP and VGCT. 


Psychologenpraktijk Brainclinics: Behandeling en therapie van ADHD (neurofeedback), Depressie (rTMS) en slaapproblemen EEG Support and neurosupplies 

As professional looking  for advice and support on equipment, products and supplies for your QEEG / EEG lab, rTMS or neurofeedback? Look at EEG Support and Neuro Supplies


Psychologenpraktijk Brainclinics: Behandeling en therapie van ADHD (neurofeedback), Depressie (rTMS) en slaapproblemen Community

In the Brainclinics community you can register yourself and become a member and thereby gain access to our many scientific publications, powerpoint presentation and other educational materials.

Also make sure to follow us on Twitter @Brainclinics or @neuroClinics






Vacature: PhD Candidate Applied Neuroscience
Onderzoeksinstituut heeft een vacature voor een PhD candidate.

Brain activity predicts personalized antidepressant treatment
Today results from the large multicenter randomized iSPOT-D study were published in Clinical Neurophysiology demonstrating that brain activity can assist in predicting antidepressant treatment outcome to commonly used antidepressant drugs. In addition, this study clearly demonstrated qualitative differences in brain activity between males and females with depression, with implications for predicting antidepressant treatment outcome.